Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NMTC

NeuroOne Medical Technologies Corp

Apr 30 • 10:37AM ET

4.69

-0.01 -0.21 %

Healthcare • Medical Devices • USA • Nano • NASD

Today, 8:50 AMNeuroOne Medical Technologies announces that CFO Ron McClurg will retire effective June 30, 2026, with current COO Chris Volker appointed as his permanent successor.

Peers: STXS NVCR PEN CNMD INGN CERS SENS AXGN TTOO

| Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.99	Insider Own	16.30%	Shs Outstand	8.40M	Perf Week	-1.26%
Market Cap	39.63M	Forward P/E	-	EPS next Y	-0.50	Insider Trans	238.28%	Shs Float	7.07M	Perf Month	0.67%
Enterprise Value	36.31M	PEG	-	EPS next Q	-0.23	Inst Own	33.07%	Short Float	0.32%	Perf Quarter	-10.15%
Income	-6.83M	P/S	4.54	EPS this Y	-38.27%	Inst Trans	-	Short Ratio	0.57	Perf Half Y	-4.30%
Sales	8.72M	P/B	6.16	EPS next Y	33.48%	ROA	-90.61%	Short Interest	0.02M	Perf YTD	3.12%
Book/sh	0.76	P/C	11.13	EPS next 5Y	59.83%	ROE	-146.27%	52W High	6.96 -32.61%	Perf Year	25.35%
Cash/sh	0.42	P/FCF	-	EPS past 3/5Y	47.63% 48.67%	ROIC	-104.86%	52W Low	3.27 43.27%	Perf 3Y	-49.24%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	78.70% 44.41%	Gross Margin	54.87%	Volatility	6.07% 8.86%	Perf 5Y	-88.42%
Dividend TTM	-	EV/Sales	4.16	EPS Y/Y TTM	37.91%	Oper. Margin	-87.71%	ATR (14)	0.35	Perf 10Y	-52.63%
Dividend Ex-Date	-	Quick Ratio	5.07	Sales Y/Y TTM	-0.38%	Profit Margin	-78.34%	RSI (14)	50.05	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	6.39	EPS Q/Q	-149.41%	SMA20	-0.21%	Beta	0.59	Target Price	11.87
Payout	-	Debt/Eq	0.04	Sales Q/Q	-53.90%	SMA50	2.45%	Rel Volume	0.33	Prev Close	4.70
Employees	18	LT Debt/Eq	0.02	Earnings	Feb 17	SMA200	-1.62%	Avg Volume	39.93K	Price	4.69
IPO	Jun 27, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	26.38% 8.93%	Trades		Volume	2,847	Change	-0.21%

Date	Action	Analyst	Rating Change	Price Target Change
May-05-25	Initiated	Ladenburg Thalmann	Buy	$1.45
Mar-29-22	Downgrade	Craig Hallum	Buy → Hold	$6 → $2

Today 08:30AM	NeuroOne(R) Announces Chief Financial Officer Succession Plan (NewMediaWire)
Apr-28-26 08:30AM	NeuroOne(R) to Report Second Quarter Fiscal Year 2026 Financial Results on Tuesday, May 12 at 8:30 a.m. Eastern Time (NewMediaWire)
Apr-15-26 08:30AM	NeuroOne(R) Advances Brain Drug Delivery Platform Through Collaboration With University of Minnesota (NewMediaWire)
Apr-14-26 08:30AM	NeuroOne(R) Medical Technologies Announces Reverse Stock Split to Regain Nasdaq Compliance (NewMediaWire)
Apr-02-26 05:18PM	NeuroOne(R) Medical Technologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (NewMediaWire)
08:30AM	Loading…
Mar-26-26 08:30AM	NeuroOne(R) Successfully Completes Limited Market Release of OneRF(R) Trigeminal Nerve Ablation System (NewMediaWire)
Mar-17-26 08:30AM	NeuroOne(R) Announces Publication of Clinical Experience With Its OneRF(R) sEEG-Guided Radiofrequency Ablation Technology (NewMediaWire)
Mar-11-26 04:01PM	NeuroOne(R) to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference March 17, 2026 at 1:20 p.m. Eastern Time (NewMediaWire)
Mar-09-26 08:30AM	NeuroOne(R) Issues Shareholder Letter and Provides Corporate Update (NewMediaWire) -6.43%
Mar-05-26 09:00AM	Next-Generation Platforms Scale Across Energy, Wellness, and Smokeless Consumer Segments (PR Newswire) +5.38%
Mar-03-26 08:30AM	NeuroOne(R) Appoints David Wambeke as Chief Business Officer; Concurrently Completes Insider Purchase of 1 Million Shares (NewMediaWire) +21.44%
Feb-26-26 08:29AM	NeuroOne(R) to Host Virtual Investor Webinar on Thursday, March 12, 2026 at 11:30 a.m. Eastern Time (NewMediaWire)
Feb-17-26 04:01PM	NeuroOne Medical Technologies Corp (NMTC) Q1 2026 Earnings Call Highlights: Navigating Revenue ... (GuruFocus.com) -16.50%
12:32PM	NeuroOne Medical Technologies Corporation Q1 2026 Earnings Call Summary (Moby)
07:30AM	NeuroOne Reports Fiscal Q1 2026 Financial Results; Expects Product Revenue of At Least $10.5 Million in Fiscal Year 2026 (NewMediaWire)
07:21AM	Loading…
Feb-16-26 07:21AM	NeuroOne Medical Technologies Corp (NMTC) Q1 2026: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Feb-04-26 04:01PM	NeuroOne(R) to Report First Quarter Fiscal Year 2026 Financial Results on Tuesday, February 17 at 8:30 a.m. Eastern Time (NewMediaWire) -6.69% -8.38%
Jan-06-26 10:00AM	Best Momentum Stocks to Buy for January 6th (Zacks) +15.50%
05:33AM	New Strong Buy Stocks for January 6th (Zacks)
Dec-22-25 07:30AM	NeuroOne(R) Appoints Jason Mills to the Board of Directors (NewMediaWire) +9.49%
Dec-18-25 08:00PM	NeuroOne Medical Technologies Corp (NMTC) Q4 2025 Earnings Call Highlights: Record Revenue ... (GuruFocus.com) +7.20%
Dec-17-25 07:30AM	NeuroOne Reports Strong Fourth Quarter Fiscal 2025 Financial Results With Product Revenue Growth of 907% to $2.7 Million and 55.8% Gross Margin & Total Revenue Growth of 163% to $9.1 Million for Fiscal Year 2025 (NewMediaWire) -5.49%
Dec-16-25 07:15AM	Earnings To Watch: NeuroOne Medical Technologies Corp (NMTC) Reports Q4 2025 Result (GuruFocus.com) +6.93%
Dec-11-25 04:00PM	NeuroOne(R) to Report Fourth Quarter and Fiscal Year 2025 Financial Results on Wednesday, December 17th at 8:30 a.m. Eastern Time (NewMediaWire) +12.38%
Dec-09-25 08:30AM	NeuroOne(R) Announces Initial Successful Cases Completed With OneRF(R) Trigeminal Nerve Ablation System at the University Hospitals in Cleveland (NewMediaWire)
Nov-19-25 08:30AM	NeuroOne(R) Announces Upcoming Industry Conference Participation (NewMediaWire)
Nov-05-25 08:30AM	NeuroOne(R) Receives 180-Day Extension From Nasdaq to Regain Minimum Bid Price Compliance (NewMediaWire)
Oct-16-25 09:31AM	NeuroOne Promotes Emily Johns to Chief Administrative Officer (NewMediaWire)
Oct-14-25 08:30AM	NeuroOne(R) Bolsters Patent Portfolio With Recent Decisions From Both the U.S. Patent & Trademark Office and European Patent Office (NewMediaWire)
Oct-06-25 04:10PM	NeuroOne Announces Preliminary Unaudited Product Revenue Growth of 163% to Record $9.1 Million, Invitation to Join Virtual Investor Webinar Tomorrow at 8:30 am EST (NewMediaWire) +7.05% +6.47%
04:00PM	Loading…
Sep-29-25 04:00PM	NeuroOne(R) Announces Virtual Investor Webinar on October 7, 2025 at 8:30 a.m. EST (NewMediaWire)
Sep-08-25 04:05PM	NeuroOne to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025 (GlobeNewswire) +7.23% +5.12%
Aug-20-25 07:12AM	NeuroOne gains FDA clearance for trigeminal nerve ablation (MedTech Dive) -6.98%
Aug-19-25 10:13AM	NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment (Zacks)
05:38AM	NeuroOnes nerve ablation system secures FDA clearance (Medical Device Network)
Aug-18-25 08:30AM	NeuroOne Receives FDA 510(k) Clearance for OneRF Trigeminal Nerve Ablation System to Treat Facial Pain (GlobeNewswire)
Aug-14-25 07:30AM	NeuroOne Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9% (GlobeNewswire)
Jul-31-25 12:12PM	NeuroOne to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update (GlobeNewswire)
08:30AM	NeuroOne to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time (GlobeNewswire)
Jul-23-25 08:30AM	NeuroOne Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office (GlobeNewswire) -12.78%
Jun-23-25 08:30AM	NeuroOne Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF Ablation System (GlobeNewswire)
Jun-03-25 08:30AM	NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary (GlobeNewswire) -5.99%
May-29-25 01:05PM	NeuroOne to Attend MedInvest's MedTech, AI & Digital Health Conference on June 3-4, 2025 (GlobeNewswire)
May-13-25 07:30AM	NeuroOne Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6% (GlobeNewswire)
May-12-25 08:30AM	NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor (GlobeNewswire)
May-05-25 04:01PM	NeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global Conference (Newsfile)
May-01-25 09:55AM	NeuroOne to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern Time (GlobeNewswire)
Apr-23-25 09:00AM	NeuroOne Completes FDA Submission for the OneRF Trigeminal Nerve Ablation System to Treat Facial Pain (GlobeNewswire) +9.45%
Apr-16-25 09:00AM	NeuroOne Issues Letter to Shareholders (GlobeNewswire)
Apr-14-25 09:00AM	NeuroOne OneRF Technology Success Story Featured on Fox News (GlobeNewswire) +17.49%
Apr-04-25 08:30AM	NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock (GlobeNewswire) -44.77%
Apr-03-25 04:05PM	NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Mar-18-25 01:12PM	NeuroOne CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace - Update (GlobeNewswire) -6.48%
09:00AM	NeuroOne CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace (GlobeNewswire)
08:46AM	NeuroOne CEO Joins Todays Marketplace To Discuss The Latest Treatments for Epilepsy (GlobeNewswire)
Mar-11-25 09:00AM	NeuroOne Accelerates Timeline of 510(k) Submission to FDA for the OneRF Trigeminal Nerve Ablation System to Treat Facial Pain (GlobeNewswire)
Mar-05-25 09:00AM	NeuroOne to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference (GlobeNewswire)
Feb-12-25 08:00AM	NeuroOne Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
Feb-05-25 11:00AM	NeuroOne to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time (GlobeNewswire)
Feb-04-25 10:56AM	NeuroOne Regains Compliance with Nasdaq Listing Requirements (GlobeNewswire) -10.11%
Jan-11-25 09:30AM	NeuroOne Reports Record Revenue Boost in Q1 2025 (TipRanks)
Jan-10-25 08:30AM	NeuroOne Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million (GlobeNewswire)
Jan-06-25 08:30AM	NeuroOne Announces Change of Virtual Investor Webinar to Friday, January 10, 2024 (GlobeNewswire) +13.04%
Jan-03-25 08:30AM	NeuroOne Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST (GlobeNewswire) +11.54%
Dec-17-24 08:30AM	NeuroOne Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025 (GlobeNewswire)
Dec-04-24 08:30AM	NeuroOne to Report Fourth Quarter and Fiscal Year 2024 Financial Results on December 17 at 9:00 a.m. Eastern Time (GlobeNewswire)
Dec-03-24 03:45PM	Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing (ACCESS Newswire)
Nov-13-24 09:30AM	NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event (ACCESSWIRE)
Oct-31-24 04:01PM	NeuroOne Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF Ablation System (GlobeNewswire)
Oct-24-24 09:00AM	NeuroOne Medical Technologies to Present at the 2024 ThinkEquity Conference (GlobeNewswire) +5.26%
Sep-24-24 09:30AM	NeuroOne Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference (GlobeNewswire) +5.40%
Sep-10-24 09:00AM	NeuroOne Announces Breakthrough Case Completed with OneRF Ablation System at the University Hospitals in Cleveland (GlobeNewswire) +11.13%
Sep-05-24 06:23PM	NeuroOne to Present at the H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire)
Aug-14-24 04:00PM	NeuroOne Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-12-24 11:30AM	NeuroOne to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14 (GlobeNewswire)
Aug-05-24 09:00AM	NeuroOne Announces $2.65 Million Equity Financing And $3.0 Million Credit Facility (GlobeNewswire) +7.25%
Jun-25-24 09:00AM	NeuroOne Announces First in Human Ablations Completed with OneRF Ablation System (GlobeNewswire) -19.08%
Jun-20-24 09:30AM	NeuroOne Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation (GlobeNewswire)
May-14-24 08:57PM	NMTC Stock Earnings: NeuroOne Medical Tech Misses EPS, Misses Revenue for Q2 2024 (InvestorPlace) -7.02%
04:00PM	NeuroOne Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
May-10-24 02:43PM	NeuroOne to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14 (GlobeNewswire)
Apr-10-24 09:00AM	NeuroOne CEO Dave Rosa Featured on Bloomberg Technology (GlobeNewswire)
Apr-09-24 09:05AM	NeuroOne Announces First Implant of OneRF Ablation Electrodes (GlobeNewswire)
Apr-04-24 09:00AM	NeuroOne CEO Dave Rosa Featured on Fox Business Network's Varney & Co. (GlobeNewswire)
Mar-26-24 09:00AM	NeuroOne Initiates Limited Commercial Launch of OneRF Ablation System (GlobeNewswire) -8.66%
Mar-08-24 12:00PM	NeuroOne to Participate in the 36th Annual Roth Conference (GlobeNewswire)
Feb-23-24 05:10PM	NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +8.41%
Feb-13-24 04:00PM	NeuroOne Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update (GlobeNewswire) -23.40%
Feb-08-24 03:30PM	NeuroOne to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13 (GlobeNewswire)
Dec-14-23 04:15PM	NeuroOne Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update (GlobeNewswire) +12.42% -11.05%
Dec-11-23 08:00AM	NeuroOne Receives FDA 510(k) Clearance to Market its OneRF Ablation System (GlobeNewswire) -10.94%
Dec-07-23 04:30PM	NeuroOne to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14 (GlobeNewswire) +7.19% +7.26%
Nov-16-23 08:00AM	NeuroOne Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe (GlobeNewswire) -8.33%
Nov-14-23 05:15PM	NeuroOne Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +11.02%
Nov-07-23 08:00AM	NeuroOne Provides Progress Update on FDA 510(k) Submission for OneRF Ablation System (GlobeNewswire) +7.48%
Oct-13-23 09:30AM	NeuroOne to Present at the ThinkEquity Conference on October 19, 2023 (GlobeNewswire)
Sep-15-23 01:01AM	Insider Buying: CFO Ronald Mcclurg Acquires 50,900 Shares of NeuroOne Medical Technologies Corp ... (GuruFocus.com) +6.00%
Sep-06-23 04:00PM	NeuroOne® to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Aug-14-23 04:00PM	NeuroOne® Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-08-23 04:00PM	NeuroOne® to Report Third Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on August 14 (GlobeNewswire)

NeuroOne Medical Technologies Corp. is a medical technology company, which engages in diagnostics, ablations, and deep brain stimulation technology for brain-related conditions. Its products include Evo Cortical, Evo sEEG, and OneRF. The company was founded by Mark Christianson on August 20, 2009 and is headquartered in Eden Prairie, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Christianson Mark	Business Development Director	Mar 30 '26	Sale	0.74	15,363	11,369	198,920	Apr 01 04:11 PM
Christianson Mark	Business Development Director	Mar 12 '26	Sale	0.80	817	654	214,383	Mar 16 03:30 PM
Christianson Mark	Business Development Director	Mar 13 '26	Sale	0.80	100	80	214,283	Mar 16 03:30 PM
Christianson Mark	Business Development Director	Mar 10 '26	Sale	0.80	11,611	9,289	217,309	Mar 12 03:58 PM
Christianson Mark	Business Development Director	Mar 11 '26	Sale	0.80	2,109	1,687	215,200	Mar 12 03:58 PM
Christianson Mark	Officer	Mar 09 '26	Proposed Sale	0.84	30,000	25,200		Mar 09 02:57 PM
Wambeke David J.	Chief Business Officer	Mar 01 '26	Buy	0.67	1,000,000	670,400	1,000,000	Mar 03 08:49 AM
Christianson Mark	Business Development Director	Sep 05 '25	Sale	0.74	30,000	22,203	231,238	Sep 09 04:15 PM
Christianson Mark	Officer	Aug 20 '25	Proposed Sale	0.81	30,000	24,210		Aug 20 01:58 PM
Christianson Mark	Business Development Director	Jun 04 '25	Sale	0.58	10,000	5,804	261,491	Jun 05 04:08 PM
Christianson Mark	Business Development Director	May 22 '25	Sale	0.62	8,967	5,586	271,491	May 23 04:03 PM
Christianson Mark	Business Development Director	May 21 '25	Sale	0.65	14	9	280,458	May 23 04:03 PM
Christianson Mark	Business Development Director	May 19 '25	Sale	0.67	8,006	5,330	283,485	May 21 04:14 PM
Christianson Mark	Business Development Director	May 20 '25	Sale	0.66	3,013	1,976	280,472	May 21 04:14 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NMTC

NeuroOne Medical Technologies Corp

Upgrade your Finviz experience